DRUG SURVIVAL RATES AND COST OF BIOLOGICAL AGENTS FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN THE BALEARIC ISLANDS (SPAIN)

被引:4
|
作者
Ventayol, P. [1 ]
机构
[1] Hosp Son Espases, Palma De Mallorca, Spain
关键词
D O I
10.1016/j.jval.2014.08.2135
中图分类号
F [经济];
学科分类号
02 ;
摘要
PSS37
引用
收藏
页码:A610 / A610
页数:1
相关论文
共 50 条
  • [1] ANNUAL COST OF BIOLOGICAL THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN SPAIN
    Dominguez-Gil, A.
    Moreno, D.
    Garcia, D.
    Campo, C.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A505 - A505
  • [2] BIOLOGICAL AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS: A PHARMACOECONOMIC ANALYSIS
    Riveros, B. S.
    Souza, T. T.
    Godoy, R. R.
    Garcia, M.
    Goncalves, P.
    Rotta, I
    Otuki, M. F.
    Pontarolo, R.
    Correr, C. J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A726 - A726
  • [3] COST OF MODERATE TO SEVERE PSORIASIS PATIENTS IN SPAIN
    Sanchez-Carazo, J. L.
    Dauden, E.
    Vanaclocha, F.
    Toribio, J.
    Pujol, R.
    Puig, L.
    Yebenes, M.
    Sabater, F. J.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A454 - A454
  • [4] EFFICIENCY (COST/EFFICACY) OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
    Lazaro, P.
    Blasco, A. J.
    Ferrandiz, C.
    Garcia, A.
    Liso, J.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A147 - A147
  • [5] COST-UTILITY ANALYSIS OF APREMILAST FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN SPAIN
    Carrascosa, J. M.
    Vanaclocha, F.
    Caloto, T.
    Echave, M.
    Oyaguez, I
    Tencer, T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A420 - A420
  • [6] Cost effectiveness of the use of infliximab compared to other biological agents (BA) in the systemic treatment of moderate to severe psoriasis
    Fonseca, M.
    Araujo, G.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A99 - A99
  • [7] EFFICIENCY OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
    Blasco, A. J.
    Lazaro, P.
    Ferrandiz, C.
    Garcia-Diez, A.
    Liso, J.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2009, 100 (09): : 792 - 803
  • [8] Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis
    Membrive-Jimenez, Cristina
    Perez-Ramirez, Cristina
    Arias-Santiago, Salvador
    Giovanni Richetta, Antonio
    Ottini, Laura
    Elena Pineda-Lancheros, Laura
    del Carmen Ramirez-Tortosa, Maria
    Jimenez-Morales, Alberto
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [9] Moderate to severe psoriasis: from topical to biological treatment
    Gardinal, I.
    Ammoury, A.
    Paul, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (11) : 1324 - 1326
  • [10] Drug survival of secukinumab for moderate-to-severe plaque psoriasis
    Lee, E. B.
    Reynolds, K. A.
    Pithadia, D. J.
    Wu, J. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 222 - 222